Top Markets
#1 Black Phoenix Black Phoenix +350.87%
#2 Islamic Coin Islamic Coin +158.26%
#3 Glidr Glidr +58.56%
#4 Cryptopia Cryptopia +20.42%
#5 DOVU DOVU +18.91%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.19%
#7 Pons Pons +9.08%
#8 MarsCoin MarsCoin +8.69%
#9 stake.link stake.link +8.24%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +7.32%
Coin of the day
Black Phoenix Black Phoenix
설정
언어
한국어
통화
USD
테마
Longevity Health Holdings Inc. Longevity Health Holdings Inc.

Longevity Health Holdings Inc.

XAGEW
주식 순위 #41843
Longevity Health Holdings Inc. is dedicated to advancing plasma-derived... Longevity Health Holdings Inc. is dedicated to advancing plasma-derived bioactive materials (PBMs) designed to stimulate tissue regeneration and recovery following injuries, illnesses, or age-related decline. Their primary product in development, CT-101, functions both as an accelerant for bone healing—with intended uses including the repair of tibia fractures, facilitating foot and ankle fusions, aiding spinal fusions, substituting for dental bone grafts, and filling bone voids—and as a tissue healing accelerator for conditions such as androgenetic alopecia and persistent wounds. This company was established in 2008 and is based in Pittsburgh, Pennsylvania.
주가
$0.01
마지막 동기화: 2025-10-22
시가총액
$8.99K
변동 (1일)
-1.96%
변동 (1년)
-53.49%
국가
US
거래 Longevity Health Holdings Inc. (XAGEW)

카테고리

Healthcare
Longevity Health Holdings Inc. (XAGEW)의 P/B 비율
2026 기준 P/B 비율 TTM: 0
Longevity Health Holdings Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/B 비율(TTM)은 0입니다. 2026년 말 기준 P/B 비율은 0였습니다.
Longevity Health Holdings Inc.의 P/B 비율 기록 (2026 ~ 2026)
매년 말 P/B 비율
연도 P/B 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/B 비율
회사 P/B 비율 P/B 비율 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR